Donepezil Treatment of Hypersomnia After COVID-19

The long-term effects of coronavirus disease-2019 (COVID-19) are not yet fully understood and some are due to central nervous system involvement. COVID-19 was reported to cause fatigue in some people after a long-term viral illness, characterized by daytime wakefulness and disturbed sleep cycles. He...

Full description

Bibliographic Details
Main Authors: Demet Aygün Üstel, Pervin İşeri, Meltem Can İke
Format: Article
Language:English
Published: Galenos Yayinevi 2021-12-01
Series:Türk Nöroloji Dergisi
Subjects:
Online Access:https://tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-29726&look4=
_version_ 1828022697101099008
author Demet Aygün Üstel
Pervin İşeri
Meltem Can İke
author_facet Demet Aygün Üstel
Pervin İşeri
Meltem Can İke
author_sort Demet Aygün Üstel
collection DOAJ
description The long-term effects of coronavirus disease-2019 (COVID-19) are not yet fully understood and some are due to central nervous system involvement. COVID-19 was reported to cause fatigue in some people after a long-term viral illness, characterized by daytime wakefulness and disturbed sleep cycles. Herein, a 90-yearold patient is presented, who developed hypersomnia after COVID-19 and showed signs of cortical atrophy in the left chronic thalamic infarction area and bilateral temporal lobe anteromedial parts in cranial magnetic resonance imaging, as well as increased wakefulness with donepezil treatment. Donepezil is an acetylcholinesterase inhibitor that increases the level of acetylcholinesterase that inhibits gamma-aminobutyric acid release in the forebrain via the serotonin system, which increases dopamine levels in the nucleus accumbens. The serotonin system has been noted for its positive effect on excessive sleepiness and Epworth sleepiness scale score improvement.
first_indexed 2024-04-10T12:14:24Z
format Article
id doaj.art-492c08b14a6f45e489424c01a365b988
institution Directory Open Access Journal
issn 1309-2545
language English
last_indexed 2024-04-10T12:14:24Z
publishDate 2021-12-01
publisher Galenos Yayinevi
record_format Article
series Türk Nöroloji Dergisi
spelling doaj.art-492c08b14a6f45e489424c01a365b9882023-02-15T16:15:50ZengGalenos YayineviTürk Nöroloji Dergisi1309-25452021-12-0127s1434510.4274/tnd.2021.29726Donepezil Treatment of Hypersomnia After COVID-19Demet Aygün Üstel0https://orcid.org/0000-0002-1828-1811Pervin İşeri1https://orcid.org/0000-0002-9582-6627Meltem Can İke2https://orcid.org/0000-0002-3991-9474Istanbul Atlas University Faculty of Medicine, Department of Neurology, Istanbul, TurkeyIstanbul Atlas University Faculty of Medicine, Department of Neurology, Istanbul, TurkeyIstanbul Atlas University Faculty of Medicine, Department of Neurology, Istanbul, TurkeyThe long-term effects of coronavirus disease-2019 (COVID-19) are not yet fully understood and some are due to central nervous system involvement. COVID-19 was reported to cause fatigue in some people after a long-term viral illness, characterized by daytime wakefulness and disturbed sleep cycles. Herein, a 90-yearold patient is presented, who developed hypersomnia after COVID-19 and showed signs of cortical atrophy in the left chronic thalamic infarction area and bilateral temporal lobe anteromedial parts in cranial magnetic resonance imaging, as well as increased wakefulness with donepezil treatment. Donepezil is an acetylcholinesterase inhibitor that increases the level of acetylcholinesterase that inhibits gamma-aminobutyric acid release in the forebrain via the serotonin system, which increases dopamine levels in the nucleus accumbens. The serotonin system has been noted for its positive effect on excessive sleepiness and Epworth sleepiness scale score improvement.https://tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-29726&look4=covid-19ultradian rhythmhypersomniadonepezil
spellingShingle Demet Aygün Üstel
Pervin İşeri
Meltem Can İke
Donepezil Treatment of Hypersomnia After COVID-19
Türk Nöroloji Dergisi
covid-19
ultradian rhythm
hypersomnia
donepezil
title Donepezil Treatment of Hypersomnia After COVID-19
title_full Donepezil Treatment of Hypersomnia After COVID-19
title_fullStr Donepezil Treatment of Hypersomnia After COVID-19
title_full_unstemmed Donepezil Treatment of Hypersomnia After COVID-19
title_short Donepezil Treatment of Hypersomnia After COVID-19
title_sort donepezil treatment of hypersomnia after covid 19
topic covid-19
ultradian rhythm
hypersomnia
donepezil
url https://tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-29726&look4=
work_keys_str_mv AT demetaygunustel donepeziltreatmentofhypersomniaaftercovid19
AT perviniseri donepeziltreatmentofhypersomniaaftercovid19
AT meltemcanike donepeziltreatmentofhypersomniaaftercovid19